Hyperglycemia was shown to promote the upregulation of mesenchymal markers and the downregulation of both H19 and endothelial cell markers, and subsequent overexpression of H19 in HG-treated HRECs dramatically reversed the trends evoked by hyperglycemia, suggesting a potential protective role for H19 in preventing EndMT in DR. This evidence concerns the gene H19 and Hyperglycemia.